Danaher stock rises on $6.26 billion quarter and $219.42 open
Published on 08/24/2026 at 19:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher Corp. (US2358511028) stock opened at $219.42 on August 24, 2026, with a market cap of $154.25 billion and a 52-week range of $160.93 to $242.80. The latest earnings report, issued on July 20, 2026, showed $1.94 in quarterly EPS on $6.26 billion of revenue.
Earnings still set the tone
The July 20 report beat consensus by $0.09 on EPS and by $140 million on revenue, based on estimates of $1.85 and $6.12 billion. Revenue rose 5.5% from the same quarter a year earlier, when Danaher posted $0.77 in EPS.
That mix matters for valuation. The shares traded at 38.97 times earnings and 2.72 times expected growth, while the stock sat above its 50-day moving average of $195.80 and 200-day average of $192.40.
Consensus remains constructive
Sell-side analysts modeled $8.53 in EPS for the current fiscal year, and the stock carried a consensus rating of Moderate Buy with an average target of $228.91. The gap between the open and that target leaves room for debate, but the current numbers already show why the shares are drawing attention.
A second point stands out: Danaher had a return on equity of 11.04% and a net margin of 15.95% in the latest quarter, which gives investors a cleaner read on profitability than the headline EPS alone.
Diagnostics and research
Danaher builds diagnostics, life sciences, and biotechnology tools, with products used across laboratories, hospitals, and industrial settings. One representative product line is the company's diagnostic and lab workflow platform, which links testing instruments with consumables and software across recurring customer use.
The shares closed the loop on August 24, 2026, at $219.42 in the market snapshot used here, leaving the stock above both long-term averages and below the 52-week high of $242.80.
Fact box
Company: Danaher Corp.
ISIN: US2358511028
Ticker: DHR
Exchange: NYSE
Price (as of August 24, 2026): $219.42 USD
Market cap: $154.25 billion
Sector / Industry: Health Care / Life Sciences Tools & Services
Index membership: S&P 500
Next earnings date: November 2026
